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3 Abstract 
4 
5 
Background 
7 
8 Increase of Metabolic syndrome (MetS) is associated with economic development and 
9 
10 changes of lifestyle. Understanding current prevalence and distribution of MetS in China is 
11 
12 important for preventing associated health complications. 
13 
14 Methods 
15 
16 
The present analysis used data from a nationally study in 2014-2015. We defined MetS by 
18 
different definitions, and compared results of the present study and previous nationally 
20 
representative studies to illustrate possible temporal changes in MetS prevalence. 
21 
22 
23 Results 
24 
25 The estimated prevalence of MetS was 18.4% by the ATP III criteria, 34.0% by the revised 
26 
27 ATP III criteria, and 26.9% by IDF criteria. The prevalence was higher in women, older 
28 
29 adults, those with lower education level, and in economically developed regions. 
30 
31 Contrasting with previous national studies, adults in urban areas had a lower rate of MetS 
32 
33 than those in rural areas (odds ratio 0.94; 95% CI 0.92 -0.97). And rural adults had worse 
34 
35 deterioration or less improvement in abdominal obesity, overweight, hypertension, and high 
36 
37 fasting plasma glucose, than urban adults, which was particularly striking for women. 
38 
39 Conclusions 
40 
41 
While measures to prevent and control cardiovascular diseases need to be strengthened in 
42 
43 
China, rapid increasing risk factors among rural residents and women should be prioritised 
44 
45 in making public health policy decisions. 
46 
47 
48 Key words: Metabolic syndrome; Prevalence; Trends; Epidemiology 
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3 Key Messages 
4 
5 1. Our study assessed prevalence and temporal changes of MetS among Chinese population 
6 
7 with the most recently completed and the largest sample size. 
8 
9 2. The current prevalence of MetS was higher in women, older adults, those with lower 
10 
11 education level, and in economically developed regions and the CVD risk factors among 
12 
13 rural residents and women should be prioritised in making public health policy decisions. 
14 
15 3. A comparison of results of the present study and previous national studies showed that 
16 rural adults had worse deterioration or less improvement in abdominal obesity, overweight, 
18 
hypertension, and high fasting plasma glucose, than urban adults, which was particularly 
20 
striking for women. 
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1 
2 
3 Introduction 
4 
5 
The morbidity and mortality of cardiovascular disease (CVD) are increasing in China, as in 
7 
other low-and-middle income countries, while CVD mortality has been declining in 
9 
high-income western countries since 1980s (1-3). The metabolic syndrome (MetS) refers to a 
10 
11 
cluster of metabolic factors associated with the risk of CVD, including abdominal obesity, 
12 
13 high blood pressure, dyslipidaemia and dysglycaemia(4). The prevalence and distribution of 
14 
15 MetS in population are important indicators for making public health decisions regarding the 
16 
17 control of CVD epidemic(5). 
18 
19 
There were several nationally representative studies that provided data on the 
21 
prevalence of MetS in China. The International Collaborative Study of Cardiovascular 
22 
23 Disease in Asia (InterASIA) in 2000-2001 was a cross-sectional study of a nationally 
24 
25 representative sample of 15,540 Chinese adults aged 35-74 years(6). In 2007-2008, A 
26 
27 sample of 46,024 Chinese aged 20 years and over were included in the National Diabetes 
28 
29 and Metabolic Disorders Survey (NDMDS)(7). The China Health and Nutrition Survey 
30 
31 (CHNS) in 2009 examined metabolic risk factors among a sample of 7488 adults(8). The 
32 
33 2010 China Noncommunicable Disease Surveillance (CNCDS) included 97,098 participants 
34 
35 from 31 provinces in China(9). Results of these national studies showed an increasingly 
36 
37 high prevalence of MetS in China. In addition, it was found that the prevalence of MetS was 
38 generally higher in women, among older adults, and in urban residents(6-9). However, it is 
40 
often difficult to compare the results of different studies, due to different sampling methods, 
42 
participant age range, and definitions of MetS used. 
44 
45 The China National Stroke Prevention Project (CSPP) survey in 2014-2015 was a 
46 
47 recently completed cross-sectional study that included 109,551 participants aged ≥40 years 
48 
49 from 30 provinces in China. In the present study, we used data from the CSPP to estimate 
50 the current prevalence of MetS in China. We also compared results of CSPP and previous 
52 
nationally representative studies to reveal changes in the prevalence of MetS over time in 
54 
China. 
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3 Methods 
4 
5 
Design and participants of the CSPP study 
7 
8 The CSPP was administrated by the National Project Office of Stroke Prevention and 
9 
10 Control, and carried out in 30 provinces in China from October 2014 to November 2015. 
11 
12 Using a 2-stage stratified cluster sampling method, 200 project areas were firstly selected in 
13 
14 proportion to the local population size and the numbers of counties. Then an urban 
15 community and a rural village were selected from each project area as primary sampling 
17 
units according to geographical locations and suggestions from local hospitals. The cluster 
19 
sampling method was used in every primary sampling unit and all residents aged≥40 years 
21 
were surveyed during the primary screening. 
22 
23 
24 All participants received information on the study and provided written informed 
25 
26 consent to participate. Questionnaire completion and physical examination were conducted 
27 by trained staff in primary health care institutions, to collect data on demographic 
29 
characteristics, medical history, behavioural risk factors, height, weight, waist 
31 
circumference, and blood pressure. The assessment of stroke risk was based on the 
32 
33 
following variables: hypertension, atrial fibrillation, current smoking, dyslipidaemia, 
34 
35 diabetes, physical inactivity, obesity or overweight (BMI ≥26kg/m2), and family history of 
36 
37 stroke. Participants with ≥3 risk factors or with prior TIA or stroke were considered at high 
38 
39 risk of stroke, and those with <3 risk factor but having hypertension, diabetes, atrial 
40 
41 fibrillation, or heart valve disorders were categorised as at intermediate risk of stroke. Low 
42 
43 risk of stroke was defined as having <3 risk factors and without the above CVD conditions. 
44 
45 According to the screening plan, participants at high risk of stroke were invited for 
46 
47 further laboratory tests, carotid ultrasound, and electrocardiogram. However, a large number 
48 
49 of participants at intermediate or low risk of stroke were also undergone additional 
50 
51 laboratory tests. A total of 726,451 participants were included in the CSPP survey in 
52 
53 2014-2015, and 109,551 of them received additional laboratory tests. In the current study, 
54 
55 the analysis of MetS was based on data from 109,551 participants who had completed all 
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5 
Data from other relevant studies 
7 
8 Data from previous nationally representative studies of MetS in China were obtained to 
9 
10 compare results of different studies and to illustrate changes in the prevalence of MetS over 
11 
12 time. We were able to access the original data from the CHNS(8, 10). For other national 
13 
14 scale studies of MetS in China (InterASIA(6), NDMDS(7), and CNDS(9)), we had to rely 
15 on results reported in published articles. We have attempted to make results from different 
17 
studies as comparable as possible in terms of participant age and the definition of Mets in 
19 
analysis. 
21 
22 Definition of Metabolic Syndrome 
23 
24 The metabolic syndrome was defined by different definitions, including National 
25 
26 Cholesterol Education Programme (NCEP) Expert Panel on Detection, Evaluation, and 
27 
28 Treatment of High Blood Cholesterol in Adults (NCEP ATP III) criteria(11), revised NCEP 
29 
30 ATP III for Asian-Americans(12), and the updated International Diabetes Federation 
31 
32 (IDF)(13) definition (see Supplementary file-1). 
33 
34 Data Analysis 
35 
36 
37 We calculated the prevalence of MetS by gender, age, location (urban or rural), and the level 
38 of socio-economic development, weighted by age and sex distribution of the 2014 population 
40 
in China. Because relatively more participants at high risk of stroke were included in the 
42 
analysis of MetS, the prevalence of MetS were weighted according to the level of stroke risk 
43 
44 
in all CSPP participants. The t test and Chi-square test were used for statistically testing 
45 
46 continuous and categorical variables. Logistic regression analysis was conducted to estimate 
47 
48 the association between MetS and other variables including age, gender, urban/rural location, 
49 
50 education level, and economic development. In addition, the discrepancy in the prevalence of 
51 
52 MetS between urban and rural areas was measured by using prevalence rate ratio(14). 
53 
54 Analyses were conducted using SPSS 19.0 (SPSS Inc., Chicago, Ill). 
55 
56 Ethical approval 
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3 The CSPP study protocol was approved by the Ethics committee of the XuanWu Hospital 
4 
5 Institutional Review Board, Capital Medical University (Beijing, China). 
6 
7 
Results 
9 
10 Table 1 shows the basic characteristics of the 109,551 participants who were included in the 
11 
12 analysis and 616,900 participants without laboratory tests. The included participants were 
13 
14 relatively older, and less likely from rural areas or under developed regions. As expected, 
15 the risk of stroke was much higher for the included participants compared with those not 
17 
included. The proportion of low risk participants was 40.2% for the included participants 
19 
and 76.3% for those who were not included. 
21 
22 The estimated prevalence of MetS by the ATP III criteria without adjusting for stroke 
23 
24 risk level was presented in supplementary file-2. The overall prevalence of MetS (ATP III 
25 
26 criteria) was 25.1%, and it was clearly associated with the level of stroke risk 
27 (supplementary file-2). After adjusting for the stroke risk, the estimated prevalence of MetS 
29 
for Chinese adults aged ≥40 in 2014-2015 was 18.4% by the ATP III criteria, 34.0% by the 
31 
revised ATP III criteria, and 26.9% by the IDF criteria (Table 2). The prevalence of MetS 
32 
33 
was statistically significantly higher in women, older adults, rural residents, adults with low 
34 
35 level of education, and in economically developed regions (Table 3). 
36 
37 
38 Comparison of results of different studies 
39 
40 We were able to compare sex- and age-specific prevalence of MetS (using the ATP III 
41 
42 definition) with the results of other three nationally representative studies (InterASIA(6), 
43 
44 CHNS(8), and CNCDS(9)) (Figure 1). The prevalence of MetS in 2014-2015 by the CSPP 
45 
46 study was generally higher than that in 2000-2001, but often lower than that in 2009 and 
47 
48 2010 (Figure 1). The high prevalence of MetS estimated by the CNCDS study in 2010 is 
49 particularly noteworthy, compared with other studies in 2000-2010, 2009, and 2014-2015. 
51 
52 Figure 2 shows the prevalence rate ratio of MetS in urban and rural areas, according to 
53 
54 results of the CSPP and four previous studies(6-9). Results of previous studies indicated a 
55 
56 higher prevalence of MetS in urban adults, with a prevalence rate ratio of 1.47 in 2000-2001, 
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1 
2 
3 1.27 in 2007-2008, 1.36 in 2009, and 1.18 in 2010. However, the overall prevalence rate 
4 
5 ratio was 0.91 (95% CI: 0.89 -0.93), indicating a lower rate of MetS in urban adults, by 
6 
7 2014-2015 (Figure 2a). While rural and urban men had similar prevalence of MetS in 
8 
9 2014-2015 (Figure 2b), rural women had a much higher prevalence than urban women in 
10 
11 2014-2015 (Figure 2c). 
12 
13 Data from three nationally representative studies (InterASIA(6), CHNS(8), and CSPP) 
14 
15 are available to compare the prevalence of MetS components in 2000-2001, 2009, and 
16 
17 2014-2015 in China (Table 4). The rate of abdominal obesity was increased by 134.5% 
18 
19 between 2000-2001 and 2009, and the increase was much greater in men than in women, 
20 
21 particularly in rural areas. The prevalence of abdominal obesity was increased by 142.4% in 
22 
23 rural areas, much greater than that (75.6%) in urban areas, between 2000-2001 and 2009. 
24 
25 The overall prevalence of abdominal obesity in China was somewhat reduced by -13.6% 
26 
27 between 2009 and 2014-2015 (Table 4). However, the reduction in the prevalence of 
28 abdominal obesity between 2009 and 2014-2015 was more substantial in urban adults, 
30 
particularly in men. Compared with that in urban adults, the prevalence of abdominal 
32 
obesity in rural adults was lower in 2000-2001 (7.2% vs. 10.1%), similarly high in 2009 
33 
34 (17.5% vs. 17.7% or 18.7% vs. 18.8%), and higher in 2014-2015 (18.7% vs. 14.5%) (Table 
35 
36 4). 
37 
38 
The overall prevalence of hypertriglyceridemia in China was increased by 36.9% 
40 
between 2000-2001 and 2009, and by 8.9% between 2009 and 20014-20015 (Table 4). The 
42 
increase was more substantial in rural adults than those in urban areas: 43.6% vs 10.7% 
44 
during 2000-2001 and 2009, and 11.9% vs. 2.2% during 2009 and 2014-2015. The 
45 
46 prevalence of hypertriglyceridemia was similarly high among rural and urban adults (38.0% 
47 
48 vs 38.4%) by 2014-2015. 
49 
50 
Results in Table 4 indicated a fluctuated change in the prevalence of low HDL 
52 
cholesterol, reduced by -24.8% between 2000-2001 and 2009 and increased by 24.7% 
54 
between 2009 and 2014-2015. The prevalence of low HDL cholesterol in 2014-2015 was 
55 
56 actually similar to that in 2000-2001. 
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2 
3 The overall prevalence of hypertension was not changed significantly between 
4 
5 2000-2001 and 2009, and increased by 15.9% between 2009 and 2014-2015 (Table 4). 
6 
7 Particularly, the recent increase in the prevalence of hypertension was greater in rural adults 
8 
9 than that in urban adults (29.7% vs. 4.5%). Rural adults had a higher prevalence of 
10 
11 hypertension than those in urban areas (58.4% vs. 48.8%) by 2014-2015. 
12 
13 The overall prevalence of high fasting glucose or diabetes in China was increased by 
14 
15 10.5% between 2000-2001 and 2009, and reduced by -14.0% between 2009 and 2014-2015. 
16 
17 Such changes were occurring mainly among male adults, particularly in rural areas. 
18 
19 Compared with urban adults, the prevalence of fasting glucose or diabetes among rural men 
20 
21 was increased more greatly (37.0% vs. 10.2%) between 2000-2001 and 2009, and reduced 
22 
23 somewhat less (-20.3% vs. -29.4%) between 2009 and 2014-2015. The prevalence of high 
24 
25 fasting glucose or diabetes was higher in urban areas in 2000-2001 and 2009, and the 
26 
27 difference between rural and urban areas was no longer obvious by 2014-2015 (Table 4). 
28 
29 The prevalence of overweight in rural adults was increased by 24.5% between 
30 
31 2000-2001 and 2009 and by 14.2% between 2009 and 2014-2015, while it was reduced by 
32 
33 -10.4% and -2.4%, respectively, in urban adults (Table 4). Compared with adults in urban 
34 
35 areas, those in rural areas had a relatively low prevalence of overweight in 2000-2001 (26.6% 
36 
37 vs. 39.1%) and in 2009 (33.1% vs. 35.1%), which was no longer the case in 2014-2015 
38 
(38.8% vs. 35.1%) (Table 4). 
40 
41 Discussions 
42 
43 
The estimated prevalence of MetS among adults aged ≥40 years in 2014-2015 in China was 
44 
45 18.4% overall (13.2% in men and 23.7% in women) by the ATP III criteria. It was 
46 
47 considerably higher by using the revised NCEP ATP III criteria (34.0% overall, 27.1% in 
48 
49 men and 40.9% in women), or by using the IDF definition (26.9% overall, 18.4% in men 
50 
51 and 35.7% in women). The overall rate of MetS (18.4% based on the ATP III definition) in 
52 
53 China remains lower than that in the United States (about 35% among adults aged ≥20 years 
54 
55 in 2011-2012)(15), in Europe (about 24%)(16), and in Brail (28.9%)(17). However, it is 
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2 
3 already a serious public health problem due to the rapid population aging, behavioural and 
4 
5 socioeconomic changes. According to the ATP III definition, 107 million Chinese adults 
6 
7 aged 40-74 had metabolic syndrome. The number of adults with abdominal obesity and 
8 
9 overweight was 96 million and 182 million, respectively, among adults aged 40-74 in 
10 
11 2014/15 in China. Furthermore, among Chinese adults aged 40-74 in 2014/15, there were 
12 
13 307 million with high blood pressure, 78 million with high fasting plasma glucose, 222 
14 
15 million with hypertriglyceridemia, and 182 million with low HDL cholesterol. The 
16 estimated number of adults with MetS will be much higher if the revised NCEP ATP III or 
18 
IDF criteria were used. 
20 
21 Compared with results of previous cross-sectional studies, the prevalence of MetS 
22 
23 estimated by the CSPP study in 2014-2015 was higher than that in 2000-2001, but often 
24 
25 lower than the estimated prevalence in 2009 and 2010. A possible explanation is that public 
26 
27 health measures taking to control cardiovascular conditions in China have some effects on 
28 reduced deterioration or increased improvement in MetS among adults. For example, the 
30 
prevalence of abdominal obesity and high fasting plasma glucose among urban adults was 
32 
lower in 2014-2015 than that in 2009. Because of different sampling and analysis methods, 
33 
34 however, the results of the across-study comparison need to be interpreted with caution, and 
35 
36 further studies are required to confirm the temporal trends in the prevalence of MetS in 
37 
38 Chinese adults. 
39 
40 
The CSPP study confirmed findings from previous studies that the prevalence of MetS 
42 
was higher in women, older adults, those with low level of education, and in economically 
44 
developed regions. Contrasting with previous nationally representative studies in China, the 
45 
46 2014-2015 CSPP study was the first to show that the MetS was more prevalent in rural 
47 
48 areas than that in urban areas. The CSPP study revealed that rural adults had worse 
49 
50 deterioration and/or less improvement in abdominal obesity, overweight, hypertension, and 
51 
52 high fasting plasma glucose, than urban adults. In addition, the discrepancy in MetS 
53 
54 between rural and urban adults was most striking for women. 
55 
56 Evidence from global nutrition transition suggested that urban residents generally have 
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2 
3 higher prevalence of obesity and overweight in low-income or less developed nations, but 
4 
5 rural  residents will catch up quickly along with economic  development(18).  For example, 
6 
7 although women with the highest wealth and education had the highest prevalence of 
8 
9 overweight and obesity in 39 low and middle income countries, the increase of overweight 
10 
11 was greater among women with the lowest wealth and education(19). The present study 
12 
13 indicated that Chinese adults in rural areas are not only catching up quickly, but also 
14 
15 possibly have overtaken those in urban areas regarding obesity and related MetS problems. 
16 
17 The speed of nutrition transition and socioeconomic development in China is uniquely 
18 
19 rapid, which will lead to swift geographic and temporal changes in MetS. Cardiovascular 
20 
21 diseases are expected to increase considerably in future due to population ageing and high 
22 
23 prevalence of MetS. However, appropriate public health measures can be implemented to 
24 
25 reduce the burden of cardiovascular diseases. It may be interesting to note that the CSPP 
26 
27 study in 2014-2015 found a lower prevalence of abdominal obesity in urban adults, 
28 compared with the CHNS study in 2009. In addition, the estimated prevalence of high 
30 
fasting plasma glucose for men in both rural and urban areas was lower in the CSPP study 
32 
in 2014-2015 compared with that in the CHNS study in 2009. However, we should not be 
33 
34 complacent as MetS components remain highly prevalent among Chinese adults. For 
35 
36 example, the prevalence of high blood pressure is high in both rural and urban areas. 
37 
38 
While efforts to prevent and control cardiovascular diseases need to be strengthened for 
40 
the whole Chinese population, health decision makers need to be aware of rapid changes in 
42 
the distribution of CVD risk factors by sub-population categories. Findings of the present 
44 
study clearly indicate that CVD risk factors among rural residents and women should be 
45 
46 prioritised in making public health policy decisions. 
47 
48 
49 Strengths and Limitations 
50 
51 The CSPP study was a nationally representative study, the most recently completed, with 
52 
53 the largest sample size to estimate the prevalence of MetS in China. In addition to the 
54 
55 current prevalence of MetS in Chinese adults, we were able to show the possible temporal 
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3 changes in MetS prevalence by comparing results of the present study and previous 
4 
5 nationally representative studies. 
6 
7 
Some limitations of the study are worth mentioning. First, the present study included 
9 
only participants who had additional laboratory test, and the prevalence of MetS will be 
10 
11 
over-estimated because high risk of stroke was more prevalent among them. However, we 
12 
13 were able to cope with this problem by adjusting the estimated prevalence of MetS 
14 
15 according to the distribution of stroke risk among all CSPP participants. 
16 
17 
To show the possible temporal changes in MetS, we made cross-study comparisons. 
19 
There may be many alternative explanations for the observed differences between the CSPP 
21 
and previous studies. Although we have attempted to make the results of different studies as 
22 
23 comparable as possible, it was difficult to be certain about the true causes of the difference 
24 
25 between different cross-sectional studies. Availability of individual participant data from all 
26 
27 relevant studies should help improve comparison of results across studies. However, so far 
28 
29 we were able to access individual participant data for only one previous study (CHNS8), in 
30 
31 addition to the CSPP study. 
32 
33 
Conclusions 
34 
35 
36 Prevalence of metabolic syndrome has been rapidly increasing and remains high, 
37 
38 particularly in women and rural areas, among middle-aged and elderly adults in China. 
39 While efforts to prevent and control cardiovascular diseases need to be strengthened for the 
41 
whole population, rapid increasing risk factors among rural residents and women should be 
43 
prioritised in making public health policy decisions. It should also be a concern for health 
44 
45 decision makers in other developing counties which are experiencing socio-economic 
46 
47 transformation. 
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5 
Figure 1: Rates of prevalence of MetS (ATP III criteria) estimated by different 
7 
nationally representative studies.  Results  of CHNS  and CSPP were obtained by analyses 
9 
of original individual participant survey data, while results of InterASIA and CNCDS were 
10 
11 
based on the published reports. The comparison of CSPP results and other studies for the 
12 
13 35-44 age group should be cautious as adults aged 35-39 were not included in the CSPP 
14 
15 survey. 
16 
17 
18 
19 
20 Figure 2: Ratio of prevalence rates of MetS in urban and rural areas in China, results 
21 
22 from five nationally representative studies between 2000/01 and 2014/15. 
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3 Table 1. The main characteristics of CSPP participants in 2014-2015 
4 
5 
6 Characteristic 
7 
Included 
(n=109551) 
Not included 
(n=616900) 
 
P value 
8 Mean age(mean, SD) 59·23±11·01 56·88±11·44 <0·001 
9 Age groups (%): <0·001 
10 
40-49 22·8 32·3 
12 50-59 28·6 29·5 
13 ≥60 48·6 38·2 
14 
Sex (%): <0·001 
15 
16 Men 45·4 47·0 
17 Women 54·6 53·0 
18 Education (%): <0·001 
19 
Primary school and below 42·3 41·4 
21 Middle school 35·0 37·1 
22 High school or the equivalent 15·5 14·8 
23 University or other tertiary degree 7·3 6·7 
24 
Location (%) <0·001 
26 Urban 52·3 46·6 
27 Rural 47·7 53·4 
28 
Economic development (%) <0·001 
29 
30 
31 
32 
33 
Stroke risk (%) <0·001 
35 Low 40·2 76·3 
36 Intermediate 10.0 14·5 
37 High (≥3 risk factors) 35·9 6·6 
38 History of TIA 5·7 1·2 
40 History of stroke 8·3 1·4 
41 Smoking status <0·001 
42 
43 
44 
45 
46 
Under developed 
Intermediately developed 
19·4 
54·2 
30·3 
43·8 
Developed 26·4 25·9 
 
Current smokers (%) 18.0 3·5  
Former smokers (%) 
Current drinking (%) 
3·4 
13·8 
0·5 
1·8 
 
<0·001 
Physical inactivity (%) 28·4 16·7 <0·001 
 
  
3 
35 
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Table 2: Prevalence of MetS by different definitions in 2014-2015 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
Notes to Table 2: Estimated rates of the prevalence were weighted by 2014 population in 
36 China and adjusted by level of stroke risk in all CSPP participants. 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60  
  
N 
% (95% CI) 
 NCEP ATP III Revised NCEP ATP III IDF 
Overall 109551 18·4% (18·2%, 18·7% 34·0% (33·7%, 34·3%) 26·9% (26·7%, 27·2%) 
Sex:     
Men 49789 13·2% (12·9%, 13·6%) 27·1% (26·7%, 27·6%) 18·4% (18·1%, 18·8%) 
Women 59762 23·7% (23·3%, 24·1%) 40·9% (40·5%, 41·3%) 35·7% (35.·3%, 
36·1%) 
Age group:     
40-49 24937 13·3% (12·8%, 13·7%) 27·3% (26·7%, 27·8%) 21·4% (20·8%, 21·9%) 
50-59 31376 18·5% (18·1%, 19·0%) 34·2% (33·6%, 34·7%) 27·4% (26·8%, 27·9%) 
>=60 53238 22·8% (22·4%, 23·2%) 39·4% (38·9%, 39·8%) 31·3% (30·9%, 31·7%) 
Location:     
Urban 57298 17·8% (17·5%, 18·2%) 33·1% (32·7%, 33·5%) 26·7% (26·3%, 27·0%) 
Rural 52253 19·6% (19·3%, 20·0%) 35·6% (35·1%, 36·0%) 27·7% (27·3%, 28·1%) 
Economic:     
Underdeveloped 21272 15·1% (14·5%, 15·7%) 30·8% (30·2%, 31·5%) 23·6% (23·0%, 24·2%) 
Intermediately 59365 19·0% (18·6%, 19·3%) 34·1% (33·7%, 34·5%) 28·7% (28·4%, 29·1%) 
Developed 28914 19·7% (19·1%, 20·2%) 34·9% (34·3%, 35·5%) 26·3% (25·8%, 26·9%) 
Smoking status:     
Never 86210 17·8% (17·6%, 18·1%) 33·3% (32·9%, 33·6%) 26·3% (26·0%, 26·6%) 
Former 3672 32·2% (30·7%, 33·7%) 49·7% (48·1%, 51·3%) 41·7% (40·1%, 43·3%) 
Current 19669 29·1% (28·4%, 29·7%) 47·2% (46·5%, 47·9%) 38·8% (38·1%, 39·5%) 
Current drinking:     
No 94485 17·8% (17·5%, 18·1%) 32·8% (32·5%, 33·1%) 25·8% (25·5%, 26·1%) 
Yes 15066 31·3% (30·6%, 32·0%) 51·4% (50·6%, 52·2%) 44·0% (43·2%, 44·8%) 
 
  
3 
8 
13 
18 
1 
2 
Table 3: Association between MetS (defined by ATP III) and selected basic variables – 
4 
results of logistic regression analysis. 
5 
6 Variables Odds ratio 95% CI P value 
7 Sex 
9 Men 1·00 
10 Women 2·11 2·05-2·17 <0·001 
11 Age 
12 
40-49 1·00 
14 50-59 1·65 1·58-1·72 <0·001 
15 ≥60 2·05 1·97-2·13 <0.001 
16 Location 
17 Rural 1·00 
19 Urban 0·94 0·92-0·97 <0·001 
20 Education 
 
 
23 
 
 
 
28 
21 Primary school and below 1·00  
22 
Middle school 1·01 0·98-1·04 0·692 
24 High school or the equivalent 0·97 0·93-1.01 0·161 
25 University or other tertiary degree 0·82 0·77-0.87 <0·001 
26 Economic development    
27 
Under developed 1·00   
29 Intermediately developed 1·08 1·04-1·12 <0·001 
30 Developed 1·20 1·15-1·25 <0·001 
31  
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
 
  
3 
1 
2 
Table 4: Prevalence of MetS components and changes over time by sex and location – 
4 
comparison of results of different studies 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
22
 
58 
59 
60  
 2000/01 
InterASIA 
(35-74) 
2009 
CHNS 
2014/15 
CSPP 
(40-74) 
Percent change % (P value) 
(35-74) (40-74) 2000/01- 2009 2009- 20014/15 
 
Abdominal obesity 
Overall 7·7 18·1 19·1 16·5 134·5 (<0·001) -13·6 (<0·001) 
Men 1·7 7·9 7·8 4·8 366·5 (<0·001) -38·1 (<0·001) 
Women 13·9 27·4 29·5 25·9 97·3 (<0·001) -12·2 (<0·001) 
Rural:       
Overall 7·2 17·5 18·7 18·7 142·4 (<0·001) 0·1 (0·992) 
Men 1·3 6·9 6·6 5·5 431·5 (<0·001) -16·0 (0.098) 
Women 13·4 27·4 29·9 29·5 104·5 (<0·001) -1·2 (0·756) 
Urban:       
Overall 10·1 17·7 18·8 14·5 75·6 (<0·001) -23·0 (<0·001) 
Men 3·1 8.5 9·0 4·3 175·.2 (<0·001) -52·1 (<0·001) 
Women 17·5 25·9 27·8 23·0 48·2 (<0·001) -17·2 (0·001) 
 
Hypertriglyceridemia 
Overall 24·8 33·9 35·1 38·2 36·9 (<0·001) 8·9 (<0·001) 
Men 24·9 38·7 38·5 39·9 55·4 (<0·001) 3·7 (0·169) 
Women 24·6 29·5 32·0 36·7 20·1 (<0·001) 14·8 (<0·001) 
Rural:       
Overall 23·1 33·2 34·0 38·0 43·6 (<0·001) 11·9 (<0·001) 
Men 22·1 37·5 37·1 39·8 69·5 (<0·001) 7·2 (0·032) 
Women 24·2 29·1 31·1 36·8 20·3 (<0·001) 18·5 (<0·001) 
Urban:       
Overall 32·3 35·8 37·6 38·4 10·7 (0·006) 2·2 (0·499) 
Men 37·0 41·4 41·7 40·3 11·8 (0·022) -3·3 (0·462) 
Women 27·3 30·7 33·8 36·7 12·6 (0·034) 8·5 (0·069) 
 
Low HDL cholesterol 
Overall 33·9 25·5 25·1 31·3 -24·8 (<0·001) 24·7 (<0·001) 
Men 21·9 17·1 16·3 20·4 -21·7 (<0·001) 25·2 (<0·001) 
Women 46·5 33·2 33·2 40·1 -28·5 (<0·001) 20·8 (<0·001) 
Rural:       
Overall 33·5 24·1 23·7 29·3 -28·0 (<0·001) 23·7 (<0·001) 
Men 29·7 15·8 14·8 20·9 -46·7 (<0·001) 41·5 (<0·001) 
Women 47·3 32·0 31·9 36·1 -32·4 (<0·001) 13·2 (<0·001) 
Urban:       
Overall 37·3 28·4 28·0 33·1 -23·8 (<0·001) 18·3 (<0·001) 
Men 29·7 20·0 19·5 20·5 -32·8 (<0·001) 5·0 (0·504) 
Women 45·3 36·0 35·7 43·4 -20·6 (<0·001) 21·6 (<0·001) 
 
  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
Note: Age range for CHNS study(8) used were different to improve the comparability 
50 
51 between studies: the InterASIA(6) aged 35-74; CHNS aged35-74 or 40-74, and CSPP aged 
52 
53 40-74. Percent change over time was calculated by: 100x(rate2-rate1)/rate1. ATP III 
54 
55 definition was used: abdominal obesity: WC ≥102cm for men and WC ≥88cm for women; 
 
High blood pressure or medication use 
Overall 41·2 40·9 45·6 52·8 -0·7 (0·731) 15·9 (<0·001) 
Men 44·2 45·7 49·5 55·8 3·3 (0·256) 12·8 (<0·001) 
Women 38.0 36·5 42·0 50·6 -3·9 (0·191) 20·5 (<0·001) 
Rural:       
Overall 41·5 40·3 45·0 58·4 -2·8 (0·250) 29·7 (<0·001) 
Men 44·2 45·1 49·0 60·8 2·0 (0·568) 24·0 (<0·001) 
Women 38·7 35·9 41·4 56·8 -7·4 (0·035) 37·2 (<0·001) 
Urban:       
Overall 40·8 42·3 46·7 48·8 3·6 (0·289) 4·5 (0·108) 
Men 45·1 47·1 50·5 52·5 4·5 (0·326) 4·1 (0·300) 
Women 36·2 38·0 43·3 45·8 4·9 (0·325) 5·7 (0·168) 
 
High fasting glucose or medication use 
Overall 12·7 14·0 15·7 13·5 10·5 (0·024) -14·0 (<0·001) 
Men 12·8 16·8 18·2 14·0 30·9 (<0·001) -23·1 (<0·001) 
Women 12·6 11·5 13·4 13·1 -8·7 (0·135) -2·2 (0·686) 
Rural:       
Overall 12·1 13·7 15·2 13·5 13·2 (0·016) -11·0 (0·007) 
Men 11·9 16·3 17·3 13·8 37·0 (<0·001) -20·3 (<0·001) 
Women 12·3 11·3 13·2 13·3 -8·5 (0·231) 0·8 (0·929) 
Urban:       
Overall 15·1 14·9 16·9 13·7 -1·3 (0·829) -18·8 (<0·001) 
Men 16·2 17·9 20·1 14·2 10·2 (0·249) -29·4 (<0·001) 
Women 13·6 12·3 13·9 13·0 -9·9 (0·147) -6·7 (0·409) 
 
Overweight (BMI≥25.0kg/m2) 
Overall 28·9 34·1 34·9 36·7 18·1 (<0·001) 5·1 (0·009) 
Men 26·9 34·3 33·9 36·6 27·4 (<0.001) 7·9 (0·007) 
Women 31·1 34·0 35·8 36·7 9·4 (0·008) 2·5 (0·366) 
Rural:       
Overall 26·6 33·1 34·0 38·8 24·5 (<0·001) 14·2 (<0·001) 
Men 23·9 32·7 32·2 36·5 36·7 (<0·001) 13·4 (<0·001) 
Women 29·5 33·6 35·6 40·7 13·7 (0·002) 14·2 (<0·001) 
Urban:       
Overall 39·1 35·1 36·0 35·1 -10·4 (0·001) -2·4 (0·452) 
Men 39·9 36·7 36·7 37·0 -8·0 (0·090) 0·9 (0·873) 
Women 38·1 33·6 35·3 33·5 -11·9 (0·007) -5·2 (0·247) 
 
  
8 
1 
2 high triglyceride: ≥1·7 mmol/L; low high-density-lipoprotein cholesterol: <1·03 mmol/L for 
3 
4 men, and <1·29 mmol/L for women; high blood pressure: SBP ≥130 or DBP ≥85 mmHg or 
5 
6 use of medication; high fasting plasma glucose: ≥6·105 mmol/L or use of medication. The 
7 estimated prevalence rates were weighted by sex and age structure of population in 2000 in 
9 
China. Results of the CSPP survey were adjusted for stroke risk. 
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4 Figure 1: Rates of prevalence of MetS (ATP III criteria) estimated by different 
5 nationally representative studies. 
7 
8 Results of CHNS(8) and CSPP (the present study) were based on original individual 
9 
10 participant data, while results of InterASIA(6) and CNCDS(9) were obtained from the 
11 
12 published reports. For the 35-44 age group, the CSPP were based on data from participants 
13 
14 aged 40-44. 
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4 Figure 2: Ratio of prevalence rates of MetS in urban and rural residents in China, 
5 results from five nationally representative studies during 2000-2001 and 2014-2015. 
7 
8 Notes to Figure 2 - The five studies are InterASIA(6), CDMDS(7), CHNS(8), CNCDS(9), and 
9 
10 CSPP survey. The prevalence rate ratio >1 indicates a higher prevalence in urban residents, 
11 
12 and <1 indicates a lower prevalence in urban residents, compared with that in rural areas. 
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Risk factors NCEP ATP III(1) Revised NCEP ATP III(2) Updated IDF(3) 
 At least three risk 
factors 
At least three risk factors Central obesity plus 2 or 
more risk factors 
central 
obesity 
Men: WC ≥102cm 
Women: WC ≥88cm 
Men: WC ≥90cm 
Women: WC ≥80cm 
Men: WC ≥90cm 
Women: WC≥80cm 
 
High BP 
SBP/DBP ≥130/85 
mmHg or taking 
anti-hypertensive 
drugs 
SBP/DBP ≥130/85 mmHg 
or taking anti-hypertensive 
drugs 
SBP/DBP ≥130/85 
mmHg or taking 
anti-hypertensive drugs 
High fasting 
plasma 
glucose 
Fasting glucose 
≥6·1mmol/L or taking 
anti-diabetic drugs 
Fasting glucose ≥ 
5·6mmol/L or taking 
anti-diabetic drugs 
Fasting glucose ≥ 
5·6mmol/L or taking 
anti-diabetic drugs 
High 
triglycerides 
Triglycerides 
≥1·7mmol/L 
Triglycerides ≥1·7mmol/L Triglycerides 
≥1·7mmol/L 
 
Low 
HDL-C 
Men: HDL-C﹤1·03 
mmol/L 
Women: HDL-C﹤ 
1·29 mmol/L 
Men: HDL-C﹤1·03 
mmol/L 
Women: HDL-C﹤1·29 
mmol/L 
Men: HDL-C﹤1·03 
mmol/L 
Women: HDL-C﹤
1·29 
mmol/L 
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7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45  
46 
47 
 Low risk Intermediate risk High risk Prior TIA Prior stroke All included 
 n % (95%CI) n % (95%CI) n % (95%CI) n % (95%CI) n % (95%CI) n % (95%CI) 
Overall 44029 12·7%(12·4-
13·0) 
10916 26·2%(25·3-
27·0) 
39301 40·3%(39·8-40·8) 6256 26·8%(25·7-
27·8) 
9049 35·3%(34·3-
36·3) 
109551 25·1%(24·9-
25·4) 
Sex: 
            
Men 19343 8·9%(8·5-9·3) 4431 18·0%(16·8-
19·1) 
19087 31·1%(30·5-
31·8) 
2311 20·9%(19·2-
22·5) 
4617 26·2%(24·9-
27·4) 
49789 19·2%(18·9-
19·6) 
Women 24686 16·6%(16·1-
17·1) 
6485 34·4%(33·3-
35·6) 
20214 49·5%(48·8-
50·2) 
3945 32·6%(31·2-
34·1) 
4432 44·5%(43·0-
46·0) 
59762 31·1%(30·7-
31·5) 
Age group: 
            
40-49 16426 10·6%(10·1-
11·1) 
1346 25·5%(23·2-
27·9) 
5658 37·2%(35·9-
38·5) 
954 23·3%(20·6-
25·9) 
553 33·7%(29·7-
37·6) 
24937 18·4%(17·9-
18·8) 
50-59 13421 13·0%(12·5-
13·6) 
3113 26·7%(25·2-
28·3) 
11139 42·1%(41·1-
43·0) 
1716 29·2%(27·1-31.4) 1987 35·9%(33·8-
38·0) 
31376 27·0%(26·5-
27·4) 
>=60 14182 14·9%(14·3-
15·5) 
6457 26·4%(25·4-
27·5) 
22504 42·4%(41·7-
43·0) 
3586 28·7%(27·3-
30·2) 
6509 36·7%(35·6-
37·9) 
53238 31·4%(31·0-
31·8) 
Location: 
            
Urban 26049 11·3%(10·9-
11·7) 
5943 24·7%(23·6-
25·8) 
17995 43·5%(42·8-
44·2) 
3024 27·5%(25·9-
29·1) 
4287 37·3%(35·9-
38·8) 
57298 24·0%(23·6-
24·3) 
Rural 17980 14·8%(14·3-
15·4) 
4973 27·7%(26·4-
28·9) 
21306 37·6%(36·9-
38·2) 
3232 26·6%(25·0-
28·1) 
4762 33·6%(32·2-
34·9) 
52253 25·6%(26·2-
26·9) 
Economic: 
            
Underdeveloped 6487 9·9%(9·2-10·7) 1490 24·6%(22·4-
26·8) 
9692 34·6%(33·7-
35·5) 
1663 26·2%(24·1-
28·3) 
1940 32·0%(29·9-
34·1) 
21272 24·0%(23·4-
24·6) 
Intermediately 26905 13·1%(12·7-
13·5) 
5987 26·4%(25·2-
27·5) 
18255 42·1%(41·4-
42·9) 
3191 27·1%(25·6-
28·6) 
5027 34·8%(33·5-
36·1) 
59365 24·8%(24·4-
25·1) 
Developed 10637 13·5%(12·8-
14·1) 
3439 26·5%(25·0-
27·9) 
11354 42·1%(41·2-
43·0) 
1402 26·6%(24·3-
29·0) 
2082 38·8%(36·7-
40·9) 
28914 27·1%(26·5-
27·6) 
Smoking status: 
            
Never 39062 12·8%(12·5-
13·2) 
9908 26·4%(25·5-
27·2) 
25827 42·7%(42·1-
43·3) 
4851 26·7%(25·5-
28·0) 
6562 34·0%(32·9-
35·2) 
86210 24·0%(23·7-
24·2) 
Former 443 23·6%(10·4-
16·8) 
133 16·8%(10·4-
23·1) 
2147 32·9%(30·9-
34·9) 
289 40·0%(34·4-
45·7) 
660 38·1%(34·4-
41·8) 
3672 31·1%(29·6-
32·6) 
Current 4524 13·7%(12·7-
14·7) 
875 28·6%(25·6-
31·6) 
11327 37·5%(36·6-
38·4) 
1116 29·2%(26·5-
31·9) 
1827 34·7%(32·5-
36·9) 
19669 31·1%(30·5-
31·8) 
Current drinking: 
            
